A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. (Q31939613)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

hospitalization

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

R C Becker

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S P Ball

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P Eisenberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Borzak

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A C Held

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

F Spencer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S J Voyce

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Jesse

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Hendel

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T Hurley

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Hebert

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

59-71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Heparin therapy for deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Assessment of Anticoagulant Treatment of Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

A Standard Heparin Nomogram for the Management of Heparin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Heparin and the activated partial thromboplastin time--a difference between the in-vitro and in-vivo effects and implications for the therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Variation among commercial activated partial thromboplastin time reagents in response to heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Erroneous activated partial thromboplastin time

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Management of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Heparin kinetics: variables related to disposition and dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia II

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970460-6

7 January 2021

Identifiers

10.1016/S0002-8703(99)70460-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9878937%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31939613&oldid=2043612182"